Funder
U.S. Department of Health & Human Services | NIH | National Cancer Institute
Leukemia and Lymphoma Society
Publisher
Springer Science and Business Media LLC
Subject
Oncology,Cancer Research,Hematology
Reference15 articles.
1. Morita K, Wang F, Jahn K, Hu T, Tanaka T, Sasaki Y, et al. Clonal evolution of acute myeloid leukemia revealed by high-throughput single-cell genomics. Nat Commun. 2020;11:5327.
2. Campbell PJ, Green AR. The myeloproliferative disorders. N Engl J Med. 2006;355:2452–66.
3. Nieborowska-Skorska M, Maifrede S, Dasgupta Y, Sullivan K, Flis S, Le BV, et al. Ruxolitinib-induced defects in DNA repair cause sensitivity to PARP inhibitors in myeloproliferative neoplasms. Blood. 2017;130:2848–59.
4. Vekariya U, Toma M, Nieborowska-Skorska M, Le BV, Caron MC, Kukuyan AM, et al. DNA polymerase theta protects leukemia cells from metabolically induced DNA damage. Blood. 2023;141:2372–89.
5. Trenner A, Sartori AA. Harnessing DNA double-strand break repair for cancer treatment. Front Oncol. 2019;9:1388.